Showing results (101-110 of 143) with videos related to
Sort By:
Pageof 15
Integrated Environmental Assessment and Management|February 9, 2008
Societal cost-benefit analysis for soil remediation in The NetherlandsAnnemarie P van Wezel, Ron O G Franken, Eric Drissen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Systematic Literature Review and Network Meta-Analysis of Treatment Outcomes in Relapsed and/or Refractory Multiple MyelomaChrissy H Y van Beurden-Tan, Margreet G Franken, Hedwig M Blommestein, et al.American Journal of Infection Control|December 4, 2014
Catheter salvage in home infusion patients with central line-associated bloodstream infectionDaniel A Caroff, Anne H Norris, Sara Keller, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1977
Electron microscopy of fibers and discs of hemoglobin S having sixfold symmetryM Ohtsuki, S L White, E Zeitler, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2010
The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematologySiok Swan Tan, Chantal W M Van Gils, Margreet G Franken, et al.Journal of Molecular Biology|September 5, 1989
Densely packed beta-structure at the protein-lipid interface of porin is revealed by high-resolution cryo-electron microscopyH J Sass, G Büldt, E Beckmann, et al.Haematologica|January 5, 2019
Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysisHedwig M Blommestein, Chrissy H Y van Beurden-Tan, Margreet G Franken, et al.Journal of Vascular Surgery|December 1, 1994
Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemiaM van den Berg, D G Franken, G H Boers, et al.The Netherlands Journal of Medicine|May 16, 2014
Access to expensive cancer drugs in Dutch daily practice: should we be concerned?H M Blommestein, M G Franken, S G R Verelst, et al.Journal of Clinical Pharmacy and Therapeutics|November 7, 2012
Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agentsJ G Gaultney, M G Franken, S S Tan, et al.Pageof 15